Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study
- PMID: 37095556
- DOI: 10.1186/s42358-023-00301-7
Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study
Abstract
Background: Early rheumatoid arthritis (RA) offers an opportunity for better treatment outcomes. In real-life settings, grasping this opportunity might depend on access to specialized care. We evaluated the effects of early versus late assessment by the rheumatologist on the diagnosis, treatment initiation and long-term outcomes of RA under real-life conditions.
Methods: Adults meeting the ACR/EULAR (2010) or ARA (1987) criteria for RA were included. Structured interviews were conducted. The specialized assessment was deemed "early" when the rheumatologist was the first or second physician consulted after symptoms onset, and "late" when performed afterwards. Delays in RA diagnosis and treatment were inquired. Disease activity (DAS28-CRP) and physical function (HAQ-DI) were evaluated. Student's t, Mann-Whitney U, chi-squared and correlation tests, and multiple linear regression were performed. For sensitivity analysis, a propensity score-matched subsample of early- vs. late-assessed participants was derived based on logistic regression. The study received ethical approval; all participants signed informed consent.
Results: We included 1057 participants (89.4% female, 56.5% white); mean (SD) age: 56.9 (11.5) years; disease duration: 173.1 (114.5) months. Median (IQR) delays from symptoms onset to both RA diagnosis and initial treatment coincided: 12 (6-36) months, with no significant delay between diagnosis and treatment. Most participants (64.6%) first sought a general practitioner. Notwithstanding, 80.7% had the diagnosis established only by the rheumatologist. Only a minority (28.7%) attained early RA treatment (≤ 6 months of symptoms). Diagnostic and treatment delays were strongly correlated (rho 0.816; p < 0.001). The chances of missing early treatment more than doubled when the assessment by the rheumatologist was belated (OR 2.77; 95% CI: 1.93, 3.97). After long disease duration, late-assessed participants still presented lower chances of remission/low disease activity (OR 0.74; 95% CI: 0.55, 0.99), while the early-assessed ones showed better DAS28-CRP and HAQ-DI scores (difference in means [95% CI]: -0.25 [-0.46, -0.04] and - 0.196 [-0.306, -0.087] respectively). The results in the propensity-score matched subsample confirmed those observed in the original (whole) sample.
Conclusions: Early diagnosis and treatment initiation in patients with RA was critically dependent on early access to the rheumatologist; late specialized assessment was associated with worse long-term clinical outcomes.
Keywords: Accessibility of health services; Delivery of healthcare; Health care outcome and process assessment; Rheumatoid arthritis; Rheumatology.
© 2023. The Author(s).
Similar articles
-
Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis.Arthritis Res Ther. 2021 Oct 27;23(1):269. doi: 10.1186/s13075-021-02651-3. Arthritis Res Ther. 2021. PMID: 34706771 Free PMC article.
-
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.Cochrane Database Syst Rev. 2019 May 24;5(5):CD010455. doi: 10.1002/14651858.CD010455.pub3. Cochrane Database Syst Rev. 2019. PMID: 31125448 Free PMC article.
-
Long-term impact of delay in assessment of patients with early arthritis.Arthritis Rheum. 2010 Dec;62(12):3537-46. doi: 10.1002/art.27692. Arthritis Rheum. 2010. PMID: 20722031
-
In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study.Clin Exp Rheumatol. 2018 Sep-Oct;36(5):806-813. Epub 2018 Feb 28. Clin Exp Rheumatol. 2018. PMID: 29533750
-
Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.Rheumatology (Oxford). 2014 Jun;53(6):1075-86. doi: 10.1093/rheumatology/ket449. Rheumatology (Oxford). 2014. PMID: 24501240 Review.
Cited by
-
[Rheumatological care in Germany : Memorandum of the German Society for Rheumatology and Clinical Immunology 2024].Z Rheumatol. 2024 Aug;83(Suppl 2):249-284. doi: 10.1007/s00393-024-01539-2. Epub 2024 Aug 13. Z Rheumatol. 2024. PMID: 39136764 German.
-
RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings.Rheumatol Int. 2025 Apr 28;45(5):129. doi: 10.1007/s00296-025-05861-z. Rheumatol Int. 2025. PMID: 40293492 Free PMC article. Clinical Trial.
-
Region-specific, data-driven guidelines are needed for rheumatic diseases in LMICs.Nat Rev Rheumatol. 2025 Aug;21(8):445-446. doi: 10.1038/s41584-025-01265-2. Nat Rev Rheumatol. 2025. PMID: 40355580 No abstract available.
-
Sex bias consideration in healthcare machine-learning research: a systematic review in rheumatoid arthritis.BMJ Open. 2025 Mar 13;15(3):e086117. doi: 10.1136/bmjopen-2024-086117. BMJ Open. 2025. PMID: 40081979 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous